全文获取类型
收费全文 | 95178篇 |
免费 | 6733篇 |
国内免费 | 2275篇 |
专业分类
耳鼻咽喉 | 643篇 |
儿科学 | 1761篇 |
妇产科学 | 1370篇 |
基础医学 | 13887篇 |
口腔科学 | 1919篇 |
临床医学 | 6022篇 |
内科学 | 13913篇 |
皮肤病学 | 1652篇 |
神经病学 | 6529篇 |
特种医学 | 2960篇 |
外国民族医学 | 3篇 |
外科学 | 8715篇 |
综合类 | 10723篇 |
现状与发展 | 9篇 |
一般理论 | 1篇 |
预防医学 | 6722篇 |
眼科学 | 1127篇 |
药学 | 14449篇 |
17篇 | |
中国医学 | 4798篇 |
肿瘤学 | 6966篇 |
出版年
2024年 | 175篇 |
2023年 | 1458篇 |
2022年 | 3264篇 |
2021年 | 3716篇 |
2020年 | 2952篇 |
2019年 | 3562篇 |
2018年 | 3343篇 |
2017年 | 3376篇 |
2016年 | 2940篇 |
2015年 | 3097篇 |
2014年 | 3844篇 |
2013年 | 5376篇 |
2012年 | 4283篇 |
2011年 | 4345篇 |
2010年 | 3345篇 |
2009年 | 3852篇 |
2008年 | 4132篇 |
2007年 | 4679篇 |
2006年 | 4414篇 |
2005年 | 4254篇 |
2004年 | 3627篇 |
2003年 | 3353篇 |
2002年 | 2709篇 |
2001年 | 2534篇 |
2000年 | 2303篇 |
1999年 | 2106篇 |
1998年 | 1551篇 |
1997年 | 1597篇 |
1996年 | 1402篇 |
1995年 | 1231篇 |
1994年 | 1181篇 |
1993年 | 1009篇 |
1992年 | 876篇 |
1991年 | 879篇 |
1990年 | 770篇 |
1989年 | 608篇 |
1988年 | 602篇 |
1987年 | 509篇 |
1986年 | 463篇 |
1985年 | 658篇 |
1984年 | 639篇 |
1983年 | 450篇 |
1982年 | 463篇 |
1981年 | 406篇 |
1980年 | 380篇 |
1979年 | 279篇 |
1978年 | 193篇 |
1977年 | 181篇 |
1976年 | 161篇 |
1975年 | 132篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features 下载免费PDF全文
22.
23.
背景与目的以免疫检查点抑制剂(immune checkpoint inhibitors, ICIs)为代表的免疫治疗越来越广泛地应用于肺癌治疗。然而,对于程序性死亡受体配体1(programmed cell death-ligand 1, PD-L1)高表达,即肿瘤比例评分(tumor proportion score, TPS)≥50%的晚期非小细胞肺癌(non-small cell lung cancer, NSCLC)患者,采用单纯免疫治疗还是免疫联合化疗在临床上仍存争议。本研究旨在评估PD-L1高表达的晚期NSCLC患者接受单纯免疫治疗与免疫联合化疗的疗效。方法本研究回顾性分析了49例PD-L1高表达晚期NSCLC患者的临床资料。PD-L1表达采用22C3抗体行免疫组化染色,按TPS判读PD-L1表达水平。比较不同临床特征分组患者的客观缓解率(objective response rate,ORR)和无进展生存时间(progression free survival, PFS)。结果免疫单药与免疫联合化疗组的ORR分别为47.1%(8/17)和43.8%(14/32),差异无统计学意义(P=0.825)。免疫单药与免疫联合化疗组的中位PFS分别为8.0个月和6.8个月,差异无统计学意义(P=0.502)。并对本组PD-L1高表达患者免疫治疗的预测因素进行了分析,结果显示,一线免疫治疗ORR(12/19, 63.2%)显著优于二线及以上免疫治疗(10/30, 33.3%),差异有统计学意义(P=0.041),二者间PFS无差异。年龄、性别、吸烟史、功能状态评分(performance status, PS)、病理类型、肿瘤大小、肿瘤淋巴结转移(tumor node metastasis, TNM)分期与ORR和PFS不相关。结论PD-L1高表达的晚期NSCLC患者接受免疫单药和免疫联合化疗的疗效相近。PD-L1高表达患者一线免疫治疗的ORR更佳。对此类人群的最佳治疗方案有待于前瞻性临床研究进一步探索。 相似文献
24.
25.
ABSTRACTThis work collates data from the analysis of complex mixtures analysed in STRmix during routine no-suspect volume crime work. It interrogates the upload rate for these types of mixtures and which component of the profile has been able to be interpreted for upload. The number of profiles giving multiple uploads and the amount of replicate PCR analysis has been collated. 相似文献
26.
27.
28.
《Saudi Pharmaceutical Journal》2020,28(7):844-849
Epilepsy is a common neurologic disorder, which is efficiently treated with carbamazepine and valproic acid. Moreover, Saudi Ministry of Health implemented a new E-system for Poison Control Centers called Awtar to enhance technology utilization in ensuring patients’ satisfaction and to improve treatment outcomes. Therefore, we conducted this study to assess appropriateness of indication of requests and therapeutic levels of carbamazepine and valproic acid in Tabuk area, North West Saudi Arabia. This is a retrospective observational study conducted in Poison Control & Forensic Chemistry Center, Tabuk, Saudi Arabia. Patients’ data were obtained for years 2018 and 2019. The blood levels of carbamazepine and valproic acid were measured by Therapeutic Drug Monitoring (TDM) Unit. We selected patients treated with either valproic acid or carbamazepine alone without any history of drug allergy. Data of 264 patients were extracted from Awtar E-system. Serum carbamazepine levels were within therapeutic range in 114 patients (75.50%), above-therapeutic range in 13 patients (8.61%) and sub-therapeutic levels in 24 patients (15.89%). Regarding serum valproic acid, it is within therapeutic range in 62 patients (54.87%), above-therapeutic range in 11 patients (9.73%) and sub-therapeutic levels in 40 patients (35.40%). In conclusion, this study gives information about partial appropriateness of usage of carbamazepine and low level of appropriateness of valproic acid. However, more efforts are needed to improve results of appropriateness of indication of antiepileptic drugs. 相似文献
29.
《Biomaterials》2015
The aim of this paper is to present a method to produce macroporous thin membranes made of poly (ethyl acrylate-co-hydroxyethyl acrylate) copolymer network with varying cross-linking density for cell transplantation and prosthesis fabrication. The manufacture process is based on template techniques and anisotropic pore collapse. Pore collapse was produced by swelling the membrane in acetone and subsequently drying and changing the solvent by water to produce 100 microns thick porous membranes. These very thin membranes are porous enough to hold cells to be transplanted to the organism or to be colonized by ingrowth from neighboring tissues in the organism, and they present sufficient tearing stress to be sutured with surgical thread. The obtained pore morphology was observed by Scanning Electron Microscope, and confocal laser microscopy. Mechanical properties were characterized by stress–strain experiments in tension and tearing strength measurements. Morphology and mechanical properties were related to the different initial thickness of the scaffold and the cross-linking density of the polymer network. Seeding efficiency and proliferation of mesenchymal stem cells inside the pore structure were determined at 2 h, 1, 7, 14 and 21 days from seeding. 相似文献
30.
《Drug discovery today》2022,27(6):1733-1742
Compounds that exhibit assay interference or undesirable mechanisms of bioactivity are routinely encountered in assays at various stages of drug discovery. We observed that assays for the investigation of thiol-reactive and redox-active compounds have not been collected in a comprehensive review. Here, we review these assays and subject them to experimental optimization to improve their reliability. We demonstrate the usefulness of our assay cascade by assaying a library of bioactive compounds, chemical probes, and a set of approved drugs. These high-throughput assays should complement the array of wet-lab and in silico assays during the initial stages of hit discovery campaigns to pursue only hit compounds with tractable mechanisms of action. 相似文献